methionine has been researched along with carbostyril in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gage, DJ; Neidhardt, FC | 1 |
| Kim, SY; Lee, J | 1 |
| Berk, S; Gajewski, TF; Ho, AW; Kuna, T; Marks, RE; Robbel, C | 1 |
| Alexander, DK; Cho, DY; Grayson, JW; Hill, HS; Lim, DJ; Mackey, C; Peña Garcia, JA; Skinner, D; Weeks, CG; Woodworth, BA; Zhang, S | 1 |
4 other study(ies) available for methionine and carbostyril
| Article | Year |
|---|---|
Adaptation of Escherichia coli to the uncoupler of oxidative phosphorylation 2,4-dinitrophenol.
Topics: 2,4-Dinitrophenol; Acclimatization; Bacterial Proteins; Coenzymes; Dinitrophenols; Enzymes; Escherichia coli; Genes, Bacterial; Kinetics; Methionine; PQQ Cofactor; Quinolones; Sulfur Radioisotopes; Uncoupling Agents | 1993 |
3-D-QSAR study and molecular docking of methionyl-tRNA synthetase inhibitors.
Topics: Binding Sites; Crystallography, X-Ray; Escherichia coli; Methionine; Methionine-tRNA Ligase; Models, Molecular; Molecular Structure; Quantitative Structure-Activity Relationship; Quinolones; Staphylococcus aureus | 2003 |
Farnesyltransferase inhibitors inhibit T-cell cytokine production at the posttranscriptional level.
Topics: Antibodies, Monoclonal; Blotting, Western; CD28 Antigens; CD3 Complex; Cells, Cultured; Enzyme Inhibitors; Extracellular Signal-Regulated MAP Kinases; Farnesyltranstransferase; HSP40 Heat-Shock Proteins; Humans; Interferon-gamma; Interleukin-2; Interleukin-4; Lymphocyte Activation; MAP Kinase Kinase 4; Methionine; Phosphorylation; Piperidines; Protein Prenylation; Pyridines; Quinolones; Ribonuclease, Pancreatic; Ribosomal Protein S6 Kinases, 70-kDa; RNA Processing, Post-Transcriptional; T-Lymphocytes; Th1 Cells; Th2 Cells | 2007 |
l-Methionine anti-biofilm activity against Pseudomonas aeruginosa is enhanced by the cystic fibrosis transmembrane conductance regulator potentiator, ivacaftor.
Topics: Aminophenols; Anti-Bacterial Agents; Biofilms; Chronic Disease; Cystic Fibrosis Transmembrane Conductance Regulator; Disease Progression; Drug Resistance; Drug Synergism; Drug Therapy, Combination; Humans; Methionine; Pseudomonas aeruginosa; Pseudomonas Infections; Quinolones; Rhinitis; Sinusitis | 2018 |